In conclusion, DHA and EPA-rich fish oil could ameliorate HFD-induced obesity and glucose intolerance partly by regulating the gut microbiome, modulating gut permeability, and promoting GLP-1 secretion. The gene discussed is GCG; the disease is Glucose intolerance.